Maintenance therapy for patients with recurrent or metastatic cervical cancer: A multicentre, cohort study

被引：0
|
作者：
Peng, Chen
Guo, Qiufen
Zhang, Tingting
Chen, Jinlong
Liu, Naifu
Yan, Peile
Lu, Yuanyuan
Ma, Anqun
Lv, Pengzhong
Liu, Jing
Xie, Peng
机构：
[1] Shandong First Med, Shandong Canc Hosp, Jinan, Peoples R China
[2] Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Jinan, Peoples R China
[3] Jilin Univ, Dept Gastrointestinal Colorectal & Anal Surg, China Japan Union Hosp, Changchun, Peoples R China
[4] Wannan Med Coll, Dept Radiat Oncol, Affiliated Hosp 1, Wuhan, Peoples R China
[5] Shandong First Med Univ, Dept Thorac Surg, East Hosp, Affiliated Prov Hosp, Jinan, Peoples R China
[6] Shandong First Med Univ, Dept Gynecol, Affiliated Hosp 1, Jinan, Peoples R China
[7] Shandong Prov Qianfoshan Hosp, Jinan, Peoples R China
[8] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Radiat Oncol, Guangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e17518
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Maintenance therapy for metastatic colorectal cancer
    Ciardiello, Fortunato
    LANCET ONCOLOGY, 2015, 16 (15): : 1444 - 1445
  • [42] Targeted therapy in locally and metastatic recurrent cervical cancers
    Geiss, Romain
    Rouge, Thibault De La Matte
    Dubot, Coraline
    Leary, Alexandra
    Lhomme, Catherine
    Pautier, Patricia
    Scholl, Suzy
    Rodrigues, Manuel Jorge
    BULLETIN DU CANCER, 2014, 101 (7-8) : 748 - 755
  • [43] The efficacy of first and second immunotherapy exposure in patients with recurrent or metastatic cervical cancer
    Ju, Mingxiu
    Pan, Baoyue
    Huang, Yongwen
    Zhou, Yun
    Chen, Jieping
    Xiang, Huiling
    Xu, Shije
    Chen, Siyu
    Lan, Chunyan
    Li, Jundong
    Zheng, Min
    CANCER MEDICINE, 2024, 13 (19):
  • [44] Phase II study of weekly topotecan in recurrent or metastatic cervical cancer: a GEICO study
    Rubio, M.
    Santaballa, A.
    Garcia, Y.
    Gonzalez, A.
    Bover, I.
    Calvo, E.
    Contreras, J. A.
    del Campo, J.
    De Juan, A.
    Poveda, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [45] Efficacy and Safety of Maintenance Therapy Using Cetuximab in Patients with Metastatic Colorectal Cancer: Retrospective Study
    Xuan, Tiantian
    Wang, Zhanmei
    Meng, Sibo
    Li, Jiaxin
    Li, Jisheng
    Cao, Fangli
    Qu, Linli
    CANCER MANAGEMENT AND RESEARCH, 2024, 16 : 185 - 197
  • [46] Recurrent pericarditis in children and adolescents: a multicentre cohort study
    Imazio, Massimo
    Brucato, Antonio
    Pluymaekers, Nikki
    Breda, Luciana
    Calabri, Giovanni
    Cantarini, Luca
    Cimaz, Rolando
    Colimodio, Filomena
    Corona, Fabrizia
    Cumetti, Davide
    Lo Cuccio, Chiara Di Blasi
    Gattorno, Marco
    Insalaco, Antonella
    Limongelli, Giuseppe
    Russoi, Maria Giovanna
    Valenti, Anna
    Finkelstein, Yaron
    Martini, Alberto
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2016, 17 (09) : 707 - 712
  • [47] Study Sees Encouraging Responses With Tisotumab Vedotin in Recurrent/Metastatic Cervical Cancer
    不详
    ONCOLOGY-NEW YORK, 2020, 34 (11): : 487 - 487
  • [48] Evaluation of Toxicity in Patients With Metastatic and Recurrent Cervical Cancer Receiving Bevacizumab after Pelvic Radiation Therapy with HDR Brachytherapy
    DeMasi, J.
    Kumar, S.
    Feddock, J. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E288 - E289
  • [49] Balstilimab and other immunotherapy for recurrent and metastatic cervical cancer
    Chinmoy K. Bose
    Medical Oncology, 2022, 39
  • [50] Treatment of locally advanced, recurrent, or metastatic cervical cancer
    Scholz, C.
    Frangini, S.
    Mallmann, P.
    ONKOLOGE, 2020, 26 (07): : 616 - 622
12345